An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases

ABSTRACT: This observational study will evaluate the efficacy and safety of bevacizumab as first-line treatment in participants with colorectal cancer and potentially resectable liver metastases.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2105921 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR